key: cord-0024005-hhc9n44k authors: Shaw, Leslee J.; Chandrashekhar, Y. title: What Is of Recent Interest in Cardiac Imaging?: Insights From the JACC Family of Journals date: 2021-12-07 journal: J Am Coll Cardiol DOI: 10.1016/j.jacc.2021.10.029 sha: 03a3ff4710c81b79cdfc9381bb782728a7b675a9 doc_id: 24005 cord_uid: hhc9n44k nan and conveys adverse prognosis. A large international cohort study (2) showed that echocardiographic abnormalities identified a high-risk group among those with elevated troponins. Does this injury leave a lasting adverse impact? The earliest cardiac magnetic resonance (CMR) study to answer this (3) showed myocardial edema (54%) and late gadolinium enhancement (LGE) (31%), raising the possibility of longer-term sequela that was confirmed to varying degrees by other studies. COVID-19 also revealed a multisystem inflammatory syndrome in kids where subtle myocardial injury was common even with preserved ejection fraction (4). The right ventricle was an important marker of poor prognosis in COVID-19 (5 Early studies showed subtle changes (9) . One of the first comprehensive, prospective studies found pericardial involvement in one-third, but frank myocarditis was rare (10), thus providing some evidence to allow cautious participation for recovering athletes (11) . (12) . Machinelearning-based FFR CT remained better than computed tomography angiography (CTA) alone, especially as the calcium burden increased (13) . Perfusion imaging generated some interesting data. Automated myocardial perfusion imaging (measured as total perfusion defect) predicted higher major adverse cardiovascular events (MACE) even when visual reads were normal, thereby showing ability to more finely characterize risk than before (14) . Another paper from the SPINS (Stress CMR Perfusion Imaging in the United States) study found stress CMR is cost effective (cost/quality-adjusted life years) and a good gatekeeper for invasive angiography (15) . Novel imaging strategies were reported. CTA is not usually recommended to evaluate patients with acute coronary syndrome (ACS). A VERDICT (Very Early Versus Deferred Invasive Evaluation Using Computerized Tomography in Patients With Acute Coronary Syndromes) trial substudy revealed very high negative predictive value allowing CTA to be a good gatekeeper for invasive angiography (16) ; however, we need more information because a very recent randomized, controlled trial (RCT) did not show a big advantage for CTA in patients with suspected ACS (17) . Finding an etiology in myocardial infarction with nonobstructive coronary arteries is challenging, and conventional LGE is the standard method to identify myocardial infarction. High-resolution LGE imaging changed the final diagnosis in about one-fourth of patients with myocardial infarction with nonobstructive coronary arteries and was most effective in patients with normal echo and conventional CMR (18) . Multisystem imaging is emerging as a powerful technique. A study in psoriasis found that chronic stress associates with noncalcified coronary plaque, possibly through its effects on the hematopoietic system activity and inflammation. Treating psoriasis attenuated these effects, including plaque progression. This might explain, in part, the high risk of cardiac events in psoriasis (19) . A couple of important papers were published regarding coronary plaque imaging. Total atherosclerotic burden but not noncalcified plaque prevalence increased with higher clinical risk profiles, but higher noncalcified plaque volume strongly predicted events in patients with multivessel disease (20) . in ACS, but such information was not traditionally used to guide interventions. A study using 3-vessel intravascular ultrasound with near-infrared spectroscopy in patients undergoing percutaneous coronary intervention for ACS found that intervening was safe, improved lumen size, and provided a nonsignificant trend toward favorable outcomes, thus paving the way for robust RCTs in this area (21) . Identifying patients at risk for stroke is challenging, but intraplaque hemorrhage seen on magnetic resonance seems to be one of the strongest markers and better than conventional parameters (22) . There is no good way to predict restenosis after peripheral vessel angioplasty, but a nice study shows that persistent femoral arterial inflammation ( 18 F-fluorodeoxyglucose positron emission tomography) and microcalcification (with sodium fluoride) postprocedure increase risk of future restenosis (23) . There were a number of important papers for imaging in heart failure in the JACC family of journals. CMR is excellent for identifying fibrosis, but how should we (34) . A large registry study shows that significant remodeling is still seen commonly after primary percutaneous coronary intervention but predicts rehospitalization and not increased mortality (35) . Empagliflozin has protective effects in diabetic and nondiabetic hearts (36) , but does it affect myocardial stiffness? A robust animal study showed that its effect on diastolic function in nondiabetic heart failure with reduced ejection fraction is associated with better remodeling, increased nitric oxide, as well as reduction in both interstitial myocardial fibrosis and improved cardiomyocyte stiffness via titin phosphorylation (37) . This raises the possibility of new and attractive strategies for intervention. Impactful papers were seen in the domain of machine learning and artificial intelligence. Deep convolutional neural network is revolutionizing imaging, but how good is it compared to highly trained cardiologists? It seems as good for detecting regional wall motion abnormalities and identifying infarction territories as our usual echo images (38) . Deep learning can automate tasks better than humans, but can it also self-correct its output? Cardiac function was automatically obtained from CMR images with quality-control not requiring any human interaction (39) . Plasma angiotensin-converting enzyme (ACE)2 is important in many conditions including COVID-19, but a fascinating study now finds its effect on LV remodeling and adverse prognosis in aortic stenosis (40) . While an increase in plasma ACE2 is detrimental, myocardial ACE2 seems to inhibit fibrosis. Similarly, fibrosis, best quantitated with extracellular volume fraction, predicted total and cardiovascular mortality in aortic stenosis independent of traditional risk variables including the presence of macroscopic scar (41) . How useful is GLS in predicting postoperative course in chronic aortic regurgitation? Even a mild reduction in preoperative GLS predicts reduced survival, and persistently low GLS on follow-up was additionally prognostic (42) . Timing surgical intervention in asymptomatic patients with severe chronic aortic regurgitation is difficult, but LV GLS is proving to be a good marker even in patients with preserved ejection fraction. Worsening GLS allows better reclassification and prognostication (43) . Ischemic mitral regurgitation is a major problem, but the effects of mitral regurgitation severity vs size of the underlying infarct remains unclear. A large CMR study shows that for similar mitral regurgitation severity, the size of the underlying scar affected outcomes, showing a role for CMR to better characterize such patients (44) . Valve embolization is a dreaded complication of transcatheter mitral valve replacement in valve-inmitral annular calcification interventions. A new score that grades mitral annular calcification systematically seems to mitigate this risk to some extent (45) . Subclinical leaflet thrombosis has generated much interest after transcatheter aortic valve replacement (TAVR), but its natural history is un- Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection Characterization of myocardial injury in patients with COVID-19 Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging Echocardiographic findings in pediatric multisystem inflammatory syndrome associated with COVID-19 in the United States Right ventricular dilation in hospitalized patients with COVID-19 infection Prognostic value of right ventricular longitudinal strain in patients with COVID-19 Prognostic utility of right ventricular remodeling over conventional risk stratification in patients with COVID-19 Multimodality cardiovascular imaging in the midst of the COVID-19 pandemic: ramping up safely to a new normal Cardiac magnetic resonance characterization of myocarditis-like acute cardiac syndrome in COVID High prevalence of pericardial involvement in college student athletes recovering from COVID-19 Screening of potential cardiac involvement in competitive athletes recovering from COVID-19: an expert consensus statement 1-year impact on medical practice and clinical outcomes of FFR CT : the ADVANCE registry Influence of coronary calcium on diagnostic performance of machine learning CT-FFR: results from MACHINE registry 5-year prognostic value of quantitative versus visual MPI in subtle perfusion defects: results from REFINE SPECT Cost-effectiveness analysis of stress cardiovascular magnetic resonance imaging for stable chest pain syndromes Coronary CT angiography in patients with non-ST-segment elevation acute coronary syndrome Early computed tomography coronary angiography in patients with suspected acute coronary syndrome: randomised controlled trial High-resolution late gadolinium enhancement magnetic resonance for the diagnosis of myocardial infarction with nonobstructed coronary arteries Chronic stress-related neural activity associates with subclinical cardiovascular disease in psoriasis: a prospective cohort study for the CAPIRE Investigators. Coronary plaque features on CTA can identify patients at increased risk of cardiovascular events Percutaneous coronary intervention for vulnerable coronary atherosclerotic plaque Prediction of stroke risk by detection of hemorrhage in carotid plaques: meta-analysis of individual patient data Vascular positron emission tomography and restenosis in symptomatic peripheral arterial disease: a prospective clinical study Extracellular volume associates with outcomes more strongly than native or post-contrast myocardial T1 CMR for identifying the substrate of ventricular arrhythmia in patients with normal echocardiography Multiparametric echocardiography scores for the diagnosis of cardiac amyloidosis Noncontrast magnetic resonance for the diagnosis of cardiac amyloidosis Low sensitivity of bone scintigraphy in detecting Phe64Leu mutation-related transthyretin cardiac amyloidosis Reduction in CMR derived extracellular volume with patisiran indicates cardiac amyloid regression Comprehensive assessment of changes in left ventricular diastolic function with contemporary breast cancer therapy Global longitudinal strain and cardiac events in patients with immune checkpoint inhibitor-related myocarditis Myocardial T1 and T2 mapping by magnetic resonance in patients with immune checkpoint inhibitor-associated myocarditis Strainguided management of potentially cardiotoxic cancer therapy Atrial dysfunction in patients with heart failure with preserved ejection fraction and atrial fibrillation Left ventricular post-infarct remodeling: implications for systolic function improvement and outcomes in the modern era Empagliflozin ameliorates adverse left ventricular remodeling in nondiabetic heart failure by enhancing myocardial energetics Empagliflozin ameliorates diastolic dysfunction and left ventricular fibrosis/ stiffness in nondiabetic heart failure: a multimodality study A deep learning approach for assessment of regional wall motion abnormality from echocardiographic images Fully automated, quality-controlled cardiac analysis from CMR: validation and large-scale application to characterize cardiac function Plasma ACE2 activity predicts mortality in aortic stenosis and is associated with severe myocardial fibrosis Extracellular myocardial volume in patients with aortic stenosis Longterm outcomes after aortic valve surgery in patients with asymptomatic chronic aortic regurgitation and preserved LVEF: impact of baseline and follow-up global longitudinal strain Incremental prognostic utility of left ventricular global longitudinal strain in asymptomatic patients with significant chronic aortic regurgitation and preserved left ventricular ejection fraction Prognostic impact of ischemic mitral regurgitation severity and myocardial infarct quantification by cardiovascular magnetic resonance a cardiac computed tomography-based score to categorize mitral annular calcification severity and predict valve embolization Subclinical leaflet thrombosis in transcatheter and surgical bioprosthetic valves: PARTNER 3 cardiac computed tomography substudy Predictors of clinical response to transcatheter reduction of secondary mitral regurgitation: the COAPT trial Safety of transesophageal echocardiography to guide structural cardiac interventions Value of echocardiographic right ventricular and pulmonary pressure assessment in predicting transcatheter tricuspid repair outcome Impact of left ventricular outflow tract calcification on procedural outcomes after transcatheter aortic valve replacement